FHIR
© HL7.org |
FHIRsmith
4.0.1 |
Server Home
|
XIG Home
|
XIG Stats
|
FHIR IG analytics
Version:
All
|
R2
|
R2B
|
R3
|
R4
|
R4B
|
R5
|
R6
Authority:
All
|
hl7
|
ihe
|
national
Realm:
All
|
au
|
be
|
br
|
ca
|
ch
|
cl
|
cr
|
cz
|
de
|
dk
|
ee
|
eu
|
fi
|
fr
|
il
|
in
|
it
|
jp
|
kr
|
nl
|
no
|
nz
|
pl
|
pt
|
se
|
stt
|
tw
|
uk
|
us
|
uv
|
vn
View:
All
|
Resource Profiles
|
Datatype Profiles
|
Extensions
|
Logical Models
|
CodeSystems
|
ValueSets
|
ConceptMaps
Resources - All Kinds, Realm US
22,974 resources (
JSON
|
CSV
)
Type:
Account
ActivityDefinition
ActorDefinition
AdministrableProductDefinition
AdverseEvent
AllergyIntolerance
Appointment
AppointmentResponse
ArtifactAssessment
AuditEvent
Basic
Binary
BiologicallyDerivedProduct
BiologicallyDerivedProductDispense
BodySite
BodyStructure
Bundle
CapabilityStatement
CarePlan
CareTeam
CatalogEntry
ChargeItem
ChargeItemDefinition
Citation
Claim
ClaimResponse
ClinicalAssessment
ClinicalImpression
ClinicalUseDefinition
CodeSystem
Communication
CommunicationRequest
Composition
ConceptMap
ConditionDefinition
Consent
Contract
Coverage
CoverageEligibilityRequest
CoverageEligibilityResponse
DetectedIssue
Device
DeviceAssociation
DeviceDefinition
DeviceDispense
DeviceMetric
DeviceRequest
DeviceUsage
DeviceUseStatement
DiagnosticReport
DocumentManifest
DocumentReference
Encounter
EncounterHistory
Endpoint
EnrollmentRequest
EnrollmentResponse
EpisodeOfCare
Evidence
EvidenceVariable
ExampleScenario
ExplanationOfBenefit
FamilyMemberHistory
Flag
FormularyItem
GenomicStudy
Goal
GraphDefinition
Group
GuidanceResponse
HealthcareService
ImagingSelection
ImagingStudy
Immunization
ImmunizationEvaluation
ImmunizationRecommendation
ImplementationGuide
Ingredient
InsurancePlan
InsuranceProduct
InventoryItem
InventoryReport
Invoice
Library
Linkage
List
Location
ManufacturedItemDefinition
Measure
MeasureReport
Media
Medication
MedicationAdministration
MedicationDispense
MedicationKnowledge
MedicationRequest
MedicationStatement
MedicinalProductDefinition
MedicinalProductManufactured
MessageDefinition
MessageHeader
MolecularDefinition
MolecularSequence
NamingSystem
NutritionOrder
Observation
ObservationDefinition
OperationDefinition
OperationOutcome
Organization
OrganizationAffiliation
PackagedProductDefinition
Parameters
Patient
PaymentNotice
PaymentReconciliation
Permission
Person
PersonalRelationship
PlanDefinition
Practitioner
PractitionerRole
Procedure
ProcedureRequest
Provenance
Questionnaire
QuestionnaireResponse
ReferralRequest
RegulatedAuthorization
RelatedPerson
RequestGroup
RequestOrchestration
Requirements
ResearchStudy
ResearchSubject
RiskAssessment
Schedule
SearchParameter
ServiceRequest
Slot
Specimen
SpecimenDefinition
StructureDefinition
StructureMap
Subscription
SubscriptionStatus
SubscriptionTopic
Substance
SubstanceDefinition
SupplyDelivery
SupplyRequest
Task
TerminologyCapabilities
TestPlan
TestReport
TestScript
Transport
ValueSet
VerificationResult
VisionPrescription
Text:
Package:
Only Show Used
By Version
R2
: 0
R2B
: 0
R3
: 578
R4
: 21,284
R4B
: 237
R5
: 875
R6
: 0
By Authority
none: 2,200
hl7
: 20,772
national
: 2
Start
Prev
Rows 13800 - 14000
Next
Package
Version
Identity
Name/Title
Status
FMM
WG
Date
Auth
Usage #
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.104.11.1031.json
Essential Hypertension
active
2017-05
hl7
2
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.104.12.1011.json
Essential Hypertension
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1040.json
Major Transplant
active
2021-09
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1042.json
Major Transplant
active
2022-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1043.json
Potentially Harmful Antihistamines for Older Adults
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1046.json
Evidence of Bilateral Oophorectomy
active
2021-09
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1048.json
Evidence of Bilateral Oophorectomy
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1049.json
Potentially Harmful Antiparkinsonian Agents for Older Adults
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1010.json
Mental Health Diagnoses
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1012.json
Mental Health Diagnoses
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1017.json
Major Depression
active
2023-01
hl7
2
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1019.json
Major Depression
active
2017-05
hl7
2
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1060.json
Major Depression In Remission
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1062.json
Major Depression In Remission
active
2025-03
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1161.json
Schizophrenia or Psychotic Disorder
active
2022-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1162.json
Schizophrenia or Psychotic Disorder
active
2022-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1163.json
Schizophrenia or Psychotic Disorder
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1206.json
Mental Behavioral and Neurodevelopmental Disorders
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1207.json
Mental Behavioral and Neurodevelopmental Disorders
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1210.json
Schizophrenia
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1211.json
Schizophrenia
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1212.json
Seizure Disorder
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1213.json
Seizure Disorder
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1214.json
REM
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1215.json
REM
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1216.json
Benzodiazepine Withdrawal
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1217.json
Benzodiazepine Withdrawal
active
2025-04
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1218.json
Alcohol Withdrawal
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1219.json
Alcohol Withdrawal
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1220.json
General Anxiety
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1221.json
General Anxiety
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.12.1004.json
Mental Health Diagnoses
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.12.1007.json
Major Depression
active
2017-05
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.12.1104.json
Schizophrenia or Psychotic Disorder
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.12.1203.json
Mental Behavioral and Neurodevelopmental Disorders
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.12.1205.json
Schizophrenia
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.12.1206.json
Seizure Disorder
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.12.1207.json
REM Sleep Behavior Disorder
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.12.1208.json
Benzodiazepine Withdrawal
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.12.1209.json
Alcohol Withdrawal
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.12.1210.json
Generalized Anxiety Disorder
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1050.json
Potentially Harmful Gastrointestinal Antispasmodics for Older Adults
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1051.json
Dipyridamole Medications
active
2021-09
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1053.json
Nifedipine Medications
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1054.json
Potentially Harmful Antidepressants for Older Adults
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1055.json
Potentially Harmful Barbiturates for Older Adults
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1057.json
Meprobamate Medications
active
2021-09
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1058.json
Potentially Harmful Estrogens for Older Adults
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1059.json
Potentially Harmful Sulfonylureas for Older Adults
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.106.11.1001.json
Substance Use Disorder
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.106.11.1003.json
Substance Use Disorder
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.106.11.1012.json
Substance Use Disorder Treatment
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.106.11.1036.json
Substance Use Disorder Treatment
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.106.12.1001.json
Substance Use Disorder
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.106.12.1005.json
Substance Use Disorder Treatment
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1060.json
Desiccated Thyroid Medications
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1062.json
Potentially Harmful Skeletal Muscle Relaxants for Older Adults
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1063.json
Potentially Harmful Pain Medications for Older Adults
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1065.json
Digoxin Medications
active
2021-09
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1066.json
Digoxin Medications
active
2024-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1067.json
Doxepin Medications
active
2021-09
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1068.json
Doxepin Medications
active
2021-09
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1001.json
Malignant Neoplasm of Colon
active
2024-11
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1003.json
Malignant Neoplasm of Colon
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1025.json
Malignant Neoplasm of Lymphatic and Hematopoietic Tissue
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1027.json
Malignant Neoplasm of Lymphatic and Hematopoietic Tissue
active
2022-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1044.json
Pap Test
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1047.json
Mammography
active
2024-11
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1051.json
Colonoscopy
active
2023-11
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1052.json
Colonoscopy
active
2017-12
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1053.json
Colonoscopy
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.11.1145.json
sDNA FIT Test
active
2017-12
hl7
2
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.12.1001.json
Malignant Neoplasm of Colon
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.12.1009.json
Malignant Neoplasm of Lymphatic and Hematopoietic Tissue
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.12.1017.json
Pap Test
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.12.1018.json
Mammography
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.12.1020.json
Colonoscopy
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.12.1038.json
CT Colonography
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.108.12.1039.json
sDNA FIT Test
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1024.json
Kidney Transplant
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1025.json
Kidney Transplant
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1026.json
Dialysis Services
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1027.json
Dialysis Services
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1028.json
Dialysis Services
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1029.json
ESRD Monthly Outpatient Services
active
2017-08
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1052.json
Kidney Transplant
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1060.json
Kidney Transplant Recipient
active
2019-03
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.11.1067.json
Kidney Transplant
active
2019-03
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.12.1012.json
Kidney Transplant
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.12.1013.json
Dialysis Services
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.12.1014.json
ESRD Monthly Outpatient Services
active
2017-05
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.109.12.1029.json
Kidney Transplant Recipient
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1065.json
DTaP Vaccine Administered
active
2021-09
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1066.json
DTaP Vaccine Administered
active
2024-11
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1068.json
Hepatitis A
active
2019-03
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1070.json
Hepatitis A
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1078.json
Measles
active
2021-09
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1080.json
Measles
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1085.json
Measles, Mumps and Rubella (MMR) Vaccine Administered
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1086.json
Measles, Mumps and Rubella (MMR) Vaccine Administered
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1087.json
Mumps
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1089.json
Mumps
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1098.json
Rubella
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.110.json
Rubella
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1104.json
Varicella Zoster
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1105.json
Varicella Zoster
active
2025-01
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1106.json
Varicella Zoster Vaccine (VZV) Administered
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1107.json
Varicella Zoster Vaccine (VZV) Administered
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1109.json
Hepatitis A Vaccine Administered
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1110.json
Hepatitis A Vaccine Administered
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1111.json
Hepatitis B Vaccine Administered
active
2021-09
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1112.json
Hepatitis B Vaccine Administered
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1115.json
Child Influenza Vaccine Administered
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1116.json
Child Influenza Vaccine Administered
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1117.json
Inactivated Polio Vaccine (IPV) Administered
active
2021-09
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1118.json
Inactivated Polio Vaccine (IPV) Administered
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1119.json
Pneumococcal Conjugate Vaccine Administered
active
2023-11
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1120.json
Rotavirus Vaccine (3 dose schedule) Administered
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1121.json
Rotavirus Vaccine (2 dose schedule) Administered
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1123.json
Genital Herpes
active
2024-03
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1124.json
Genital Herpes
active
2024-03
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1128.json
Lab Tests for Sexually Transmitted Infections
active
2022-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1129.json
Chlamydia Screening
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1133.json
Pneumococcal Conjugate Vaccine Administered
active
2024-11
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1135.json
HPV Test
active
2024-11
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1148.json
Rotavirus Vaccine (2 Dose Schedule) Administered
active
2019-03
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1149.json
Rotavirus Vaccine (3 Dose Schedule) Administered
active
2019-03
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1150.json
Advanced Illness
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1151.json
Advanced Illness
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1152.json
HiB Vaccine (3 dose schedule)
active
2021-12
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1153.json
HiB Vaccine (3 dose schedule) Administered
active
2021-09
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1154.json
HiB Vaccine (4 dose schedule)
active
2021-09
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1155.json
HiB Vaccine (4 dose schedule) Administered
active
2021-09
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1156.json
HiB Vaccine (3 dose schedule) Administered
active
2024-03
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1157.json
HiB Vaccine (4 dose schedule) Administered
active
2024-03
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1158.json
Competing Conditions for Respiratory Conditions
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1159.json
Competing Conditions for Respiratory Conditions
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1022.json
DTaP Vaccine Administered
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1024.json
Hepatitis A
active
2017-05
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1031.json
Measles, Mumps and Rubella (MMR) Vaccine Administered
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1032.json
Mumps
active
2017-05
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1037.json
Rubella
active
2017-05
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1039.json
Varicella Zoster
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1040.json
Varicella Zoster Vaccine (VZV) Administered
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1041.json
Hepatitis A Vaccine Administered
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1042.json
Hepatitis B Vaccine Administered
active
2022-09
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1044.json
Child Influenza Vaccine Administered
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1045.json
Inactivated Polio Vaccine (IPV) Administered
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1046.json
Pneumococcal Conjugate Vaccine Administered
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1047.json
Rotavirus Vaccine (3 dose schedule) Administered
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1048.json
Rotavirus Vaccine (2 dose schedule) Administered
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1049.json
Genital Herpes
active
2018-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1051.json
Lab Tests for Sexually Transmitted Infections
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1052.json
Chlamydia Screening
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1053.json
Measles
active
2017-05
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1059.json
HPV Test
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1082.json
Advanced Illness
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1083.json
Hib Vaccine (3 dose schedule)
active
2019-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1084.json
Hib Vaccine (3 dose schedule) Administered
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1085.json
Hib Vaccine (4 dose schedule)
active
2019-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1086.json
Hib Vaccine (4 dose schedule) Administered
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1087.json
Influenza Virus LAIV Vaccine
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1088.json
Influenza Virus LAIV Vaccine Administered
active
2021-02
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1012.json
Lab Tests During Pregnancy
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1013.json
Diagnostic Studies During Pregnancy
active
2022-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1019.json
Pregnancy Test
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1022.json
Complications of Pregnancy, Childbirth and the Puerperium
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1023.json
Complications of Pregnancy, Childbirth and the Puerperium
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1028.json
Procedures for Sexual Activity
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1030.json
Procedures for Sexual Activity
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1031.json
Diagnosis for Sexual Activity
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1032.json
Diagnosis for Sexual Activity
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1033.json
Procedures for Sexual Activity
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1007.json
Lab Tests During Pregnancy
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1008.json
Diagnostic Studies During Pregnancy
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1011.json
Pregnancy Test
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1012.json
Complications of Pregnancy, Childbirth and the Puerperium
active
2022-03
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1016.json
Congenital or Acquired Absence of Cervix
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1017.json
Procedures Used to Indicate Sexual Activity
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1018.json
Diagnoses Used to Indicate Sexual Activity
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.112.11.1024.json
Absence of Cervix
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.112.11.1025.json
Absence of Cervix
active
2021-09
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.112.11.1026.json
Absence of Cervix
active
2023-09
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1073.json
Osteoporosis Without Current Fracture
active
2017-12
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1074.json
Osteoporosis Without Current Fracture
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1200.json
Osteoporosis With Current Fracture
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1201.json
Osteoporosis With Current Fracture
active
2024-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1202.json
DXA (Dual energy Xray Absorptiometry) Scan Non Hip or Spine
active
2021-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1308.json
Frailty Diagnosis
active
2024-11
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1309.json
Frailty Diagnosis
active
2025-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1310.json
Frailty Symptom
active
2023-02
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1311.json
Frailty Symptom
active
2023-11
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.12.1038.json
Osteoporosis Without Current Fracture
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.12.1050.json
Osteoporosis With Current Fracture
active
2018-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.12.1051.json
DXA (Dual energy Xray Absorptiometry) Scan
active
2022-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.12.1074.json
Frailty Diagnosis
active
2019-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.12.1075.json
Frailty Symptom
active
2019-03
hl7
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.11.1021.json
Narcolepsy
active
2018-08
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.11.1023.json
Narcolepsy
active
2017-05
hl7
1
us.nlm.vsac
R4
ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.11.1024.json
Neurologic impairment
active
2024-02
hl7
1